Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Adaptimmune Therapeutics PLC ADR | 2 | 0 | 2 | 0 | €1.12 | €1.70 | 51.786% |
| Dexcom Inc. | 18 | 0 | 2 | 0 | €119.28 | €136.82 | 14.707% |
| Personalis Inc | 6 | 0 | 2 | 0 | €1.50 | €3.24 | 116.640% |
| Laboratory Corp. Of America (labcorp) | 11 | 0 | 2 | 0 | €188.00 | €237.94 | 26.564% |
| Idexx Laboratories Inc. | 11 | 0 | 2 | 0 | €446.50 | €552.72 | 23.789% |
| Esperion Therapeutis.Inc. | 13 | 0 | 2 | 0 | €1.94 | €8.39 | 332.948% |
| Blueprint Medicines Corp | 2 | 0 | 2 | 0 | €99.52 | - | - |
| Viracta Therapeutics Inc. | 2 | 0 | 2 | 0 | €0.74 | - | - |
| Fresenius Medical Care AG & Co KGaA ADR | 4 | 1 | 2 | 0 | €19.50 | €21.00 | 7.692% |
| Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
| R1 RCM Inc. | 19 | 0 | 2 | 0 | €11.40 | €17.21 | 50.988% |
| Fate Therapeutics Inc. | 5 | 2 | 2 | 1 | €3.78 | €8.27 | 118.625% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €72.00 | €75.94 | 5.467% |
| Masimo Corp. | 7 | 1 | 2 | 0 | €127.05 | €147.62 | 16.187% |
| Rhythm Pharmaceuticals | 14 | 0 | 2 | 0 | €40.60 | €46.19 | 13.756% |
| Insmed Inc. | 13 | 1 | 2 | 1 | €23.80 | €44.01 | 84.902% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.28 | €8.50 | 2.719% |
| Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €30.60 | €38.99 | 27.414% |
| XOMA Corp. | 6 | 0 | 3 | 0 | €24.20 | €68.78 | 184.212% |
| MacroGenics Inc. | 11 | 0 | 3 | 0 | €14.20 | €20.00 | 40.845% |
| Pfizer Inc. | 31 | 4 | 3 | 1 | €25.85 | €41.10 | 59.006% |
| Viking Therapeutics Inc | 6 | 0 | 3 | 0 | €71.48 | €100.00 | 39.899% |
| Dentsply Sirona Inc. | 13 | 0 | 3 | 0 | €26.28 | €37.86 | 44.077% |
| AnaptysBio Inc | 8 | 1 | 3 | 0 | €24.80 | €46.24 | 86.452% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €365.20 | €421.61 | 15.445% |